CIK 0001782303
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Boundless Bio, Inc.
Sign in to watch- Ticker
- BOLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830751369
- Phone
- +1 858-766-9912
- Business address
- 11099 NORTH TORREY PINES ROAD, SUITE 150, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $735,756
- in 7 filings
- Open-market sales, last 90 days
- $54,351
- in 1 filing
Net +$681,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Lim Jonathan E Director | Grant or award · Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2025-06-23 | Lim Jonathan E Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-06-20 | Lim Jonathan E Director | Grant or award · Stock Option (Right to Buy) | +6,610 | 6,610 | ||
| 2024-04-02 | Lim Jonathan E Director | Conversion | +525,274 | 550,915 | ||
| 2024-04-02 | Lim Jonathan E Director | Conversion · Series A Convertible Preferred Stock | −512,820 | 0 | ||
| 2024-04-02 | Lim Jonathan E Director | Conversion · Series B Convertible Preferred Stock | −5,128 | 0 | ||
| 2024-04-02 | Lim Jonathan E Director | Conversion · Series C Convertible Preferred Stock | −7,326 | 0 | ||
| 2024-03-27 | Lim Jonathan E Director | Grant or award · Stock Option | +13,219 | 13,219 |
Page 1 of 1 · 8 trades